J&J, Merck, Boston Scientific Debut Trio Of Splashy Takeovers Topping $3 Billion In Value
J&J, Merck and Boston Scientific kicked off the year's biggest medical conference with a trio of takeovers. AMAM stock and HARP stock soared.
Axonic's stock soars after cash buyout deal with Boston Scientific valued at $3.7 billion
Shares of Axonics Inc. AXNX, -0.84% soared 19.2% toward a 13-month high in premarket trading Monday, after the medical technology company focused on treating urinary and bowel dysfunction announced...
Boston Scientific (BSX) Rides on Global Growth Amid Macro Woes
Within APAC, Boston Scientific (BSX) is registering strong growth in Japan and China.
Boston Scientific (BSX) Initiates AVANT GUARD Clinical Trial
Boston Scientific's (BSX) AVANT GUARD clinical trial is set to evaluate the FARAPULSE PFA System as the first-line treatment for persistent AF.
These Two Stocks Rocked During 2023 And Are Stretching To New Highs
TJX stock hit a buy point and a new high on Friday as 2023 wraps up. A medical device stock also hit a buy point and a new high.
Midday Movers: Boston Scientific Heart System, Tesla Cybertruck Accident
U.S. equities were lower at midday on this last trading day of 2023. The Dow, S&P 500, and Nasdaq were down, although all three are likely to end of the year with solid gains.
Boston Scientific (BSX) Hits 52-Week High: What's Aiding It?
Investors are optimistic about Boston Scientific's (BSX) impressive market share gain in the MedSurg segment.
Boston Scientific (BSX) Gains From Global Expansion, FX Woe Ails
Boston Scientific's (BSX) Endoscopy business within MedSurg benefits from strong worldwide demand for its broad range of GI and pulmonary treatment options.
3 Healthcare Stocks to Pick Up Before the Year-End Rally
With their robustness and growth potential, healthcare stocks are becoming a focal point in portfolios worldwide. Moreover, the U.S. stands out at the forefront of healthcare spending, allocating a...
Could Ozempic Harm These 3 Medical Device Stocks?
Ozempic could make some medical devices less necessary than before. If that happens, it would lead to lower revenue for the device makers.
3 Healthcare Stocks to Scoop Up as They Change the Medical Landscape
The U.S. continues to spend more money on healthcare than any other country. Healthcare spending totaled $4.3 trillion, according to the American Medical Association.
Boston Scientific (BSX) Closes the Relievant Medsystems Buyout
Boston Scientific (BSX) expands the neuromodulation portfolio with the acquisition of Relievant Medsystems.
Boston Scientific (BSX) Q3 Earnings Beat, Gross Margin Dips
Boston Scientific's (BSX) organic and operational revenues at its respective core business segments and geographies rise in the third quarter.
Boston Scientific (BSX) Tops Q3 Earnings and Revenue Estimates
Boston Scientific (BSX) came out with quarterly earnings of $0.50 per share, beating the Zacks Consensus Estimate of $0.48 per share. This compares to earnings of $0.43 per share a year ago.
Boston Scientific posts better-than-expected Q3 earnings
Boston Scientific Corp. BSX, -1.90% posted better-than-expected third-quarter earnings early Thursday and raised its full-year guidance. The medical technology company had net income of $505 millio...
Related Companies